Cangrelor PK/PD analysis in post‐operative neonatal cardiac patients at risk for thrombosis-Reference-Cited by-同舟云学术

Cangrelor PK/PD analysis in post‐operative neonatal cardiac patients at risk for thrombosis

Published:2020-11-29 Issue:1 Volume:19 Page:202-211
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Vargas Diana¹,Zhou Hairu²,Yu Xinren³,Diamond Scott³,Yeh Justin⁴,Allada Vivekanand²,Krishnamurthy Ganga¹,Price Mary⁵,Allen Beverly⁵,Alexander James⁵,Schmidhofer Joseph²,Kreutzer Jacqueline²,Vincent Julie¹,Morell Victor⁶,Bacha Emile⁷,Diacovo Thomas²

Affiliation:

1. Department of Pediatrics Columbia University Medical Center New York NY USA

2. Department of Pediatrics University of Pittsburgh School of Medicine Pittsburgh PA USA

3. Department of Chemical and Biomolecular Engineering University of Pennsylvania Philadelphia PA USA

4. Department of Critical Care Medicine University of Pittsburgh School of Medicine Pittsburgh PA USA

5. Chiesi USA Cary NC USA

6. Department of Surgery University of Pittsburgh School of Medicine Pittsburgh PA USA

7. Department of Surgery Columbia University School of Medicine New York NY USA

Funder

National Center for Research Resources

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15141

Reference31 articles.

1. Thrombosis in children with BT shunts, Glenns and Fontans

2. Interim mortality in infants with systemic-to–pulmonary artery shunts

3. Risk Factors for Mortality and Morbidity After the Neonatal Blalock-Taussig Shunt Procedure

4. Incidence and Management of Thrombotic and Thromboembolic Complications Following the Norwood Procedure: A Systematic Review

5. Early systemic-to-pulmonary artery shunt intervention in neonates with congenital heart disease

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, Tolerability, and Pharmacodynamics of AZD3366 (Optimized Human CD39L3 Apyrase) Alone and in Combination With Ticagrelor and Acetylsalicylic Acid: A Phase 1, Randomized, Placebo‐Controlled Study;Journal of the American Heart Association;2024-06-04

2. ACR Appropriateness Criteria® Congenital or Acquired Heart Disease;Journal of the American College of Radiology;2023-11

3. Cangrelor Dosing and Monitoring for Prevention of Acute Systemic-to-Pulmonary Artery Shunt Thrombosis in Neonates;The Journal of Pediatric Pharmacology and Therapeutics;2022-11-17

4. Impact of Reticulated Platelets on Platelet Reactivity in Neonates;Journal of Cardiovascular Pharmacology and Therapeutics;2021-08-23